A detailed history of Canada Pension Plan Investment Board transactions in Eli Lilly & CO stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 1,107,112 shares of LLY stock, worth $885 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
1,107,112
Previous 927,153 19.41%
Holding current value
$885 Million
Previous $839 Million 16.85%
% of portfolio
0.99%
Previous 0.87%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $139 Million - $173 Million
179,959 Added 19.41%
1,107,112 $981 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $99.6 Million - $125 Million
137,418 Added 17.4%
927,153 $839 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $92.3 Million - $123 Million
-155,797 Reduced 16.48%
789,735 $614 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $49.5 Million - $58.4 Million
-94,300 Reduced 9.07%
945,532 $551 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $58.7 Million - $80.9 Million
135,000 Added 14.92%
1,039,832 $559 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $12.2 Million - $16.4 Million
-34,900 Reduced 3.71%
904,832 $424 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $41 Million - $48.2 Million
132,000 Added 16.34%
939,732 $323 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $9.4 Million - $11 Million
-29,240 Reduced 3.49%
807,732 $296 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $19.1 Million - $21.7 Million
-64,303 Reduced 7.13%
836,972 $271 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $10.1 Million - $11.8 Million
-36,160 Reduced 3.86%
901,275 $292 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $136 Million - $168 Million
-577,432 Reduced 38.12%
937,435 $268 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $68.2 Million - $84.7 Million
303,481 Added 25.05%
1,514,867 $418 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $42.6 Million - $52.4 Million
-192,239 Reduced 13.7%
1,211,386 $280 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $53.4 Million - $69 Million
295,518 Added 26.67%
1,403,625 $322 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $50.8 Million - $65.8 Million
309,111 Added 38.69%
1,108,107 $207 Million
Q4 2020

Feb 17, 2021

SELL
$130.46 - $172.63 $13 Million - $17.2 Million
-99,473 Reduced 11.07%
798,996 $135 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $52.9 Million - $61.1 Million
361,500 Added 67.32%
898,469 $133 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $4.7 Million - $5.66 Million
-34,451 Reduced 6.03%
536,969 $88.2 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $25.8 Million - $32 Million
217,135 Added 61.29%
571,420 $79.3 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $24.9 Million - $30.8 Million
-232,729 Reduced 39.65%
354,285 $46.6 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $23.1 Million - $25.1 Million
-216,506 Reduced 26.94%
587,014 $65.6 Million
Q2 2019

Aug 12, 2019

BUY
$110.79 - $129.32 $38.7 Million - $45.2 Million
349,179 Added 76.85%
803,520 $89 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $199 Million - $234 Million
-1,786,093 Reduced 79.72%
454,341 $59 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $7.69 Million - $9.08 Million
-103,600 Reduced 4.42%
2,240,434 $173 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $14 Million - $15 Million
170,500 Added 7.84%
2,344,034 $198 Million
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $9.69 Million - $10.7 Million
125,670 Added 6.14%
2,173,534 $186 Million
Q2 2017

Jan 31, 2018

BUY
N/A
741,430 Added 56.75%
2,047,864 $169 Million
Q1 2017

Jan 31, 2018

BUY
N/A
1,306,434
1,306,434 $110 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.